3 months Here’s Why Acurx Pharmaceuticals (ACXP) Is a Great ‘Buy the Bottom’ Stock Now Zacks

   X     

3 months Ionis Pharmaceuticals (IONS) Upgraded to Buy: What Does It Mean for the Stock? Zacks

   X     

3 months NRx Pharmaceuticals (NRXP) Upgraded to Buy: Here’s Why Zacks

   X     

3 months SRPT Inks $11B Licensing Deal With Arrowhead for Rare Gene Therapies Zacks

   X     

3 months ACAD Signs License Deal With Saniona for Rights to Neurology Drug Zacks

   X     

3 months Despite Fast-paced Momentum, Sonoma Pharmaceuticals (SNOA) Is Still a Bargain Stock Zacks

   X     

3 months Arrowhead Pharmaceuticals, Inc. (ARWR) Q4 2024 Earnings Call Transcript Seeking Alpha

   X     

3 months Does ANI (ANIP) Have the Potential to Rally 31.31% as Wall Street Analysts Expect? Zacks

   X     

3 months Is Agios Pharmaceuticals (AGIO) Stock Outpacing Its Medical Peers This Year? Zacks

   X     

3 months FDA Begins Review of Alnylam’s sNDA for Expanded Amvuttra Use Zacks

   X     

3 months Arrowhead, Sarepta Skyrocket After Duo Inks A Whopping $11.38 Billion Deal Investor's Business Daily

   X     

3 months Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know Zacks

   X     

3 months The Zacks Analyst Blog Costco, T-Mobile US, Uber Technologies, SandRidge and Elite Pharmaceuticals Zacks

   X     

3 months Enanta Pharmaceuticals (ENTA) Reports Q4 Loss, Misses Revenue Estimates Zacks

   X     

3 months Adial Pharmaceuticals (ADIL) Upgraded to Buy: Here’s What You Should Know Zacks

   X     

3 months Do Options Traders Know Something About Regeneron (REGN) Stock We Don’t? Zacks

   X     

3 months Ligand Pharmaceuticals: Buy This Strong Growing Pharma And Get A Stake In Dozens Of Therapies Seeking Alpha

   X     

3 months Avadel Pharmaceuticals: Despite My Sympathies For The Company, Stock Looks Risky Seeking Alpha

   X     

3 months Madrigal (MDGL) Just Flashed Golden Cross Signal: Do You Buy? Zacks

   X     

3 months Is Atea Pharmaceuticals (AVIR) Stock Outpacing Its Medical Peers This Year? Zacks

   X     

3 months Warren Buffett’s Stock Selling is Sending a Big Signal Zacks

   X     

3 months JAZZ Secures FDA Approval for Ziihera in Biliary Tract Cancer Zacks

   X     

3 months PFE vs. NVO: Which Stock Is the Better Value Option? Zacks

   X     

3 months MCK Stock Down Despite Latest Partnership to Boost SCD Treatment Zacks

   X     

3 months Sun Pharmaceuticals Elliott Wave technical analysis [Video] FXStreet

   X     

3 months ANI (ANIP) Upgraded to Buy: What Does It Mean for the Stock? Zacks

   X     

3 months ARS Pharmaceuticals: Demand Curve Is Key Unknown Seeking Alpha

   X     

3 months Acurx to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy’s playbook CNBC

   X     

3 months Is Trending Stock AbbVie Inc. (ABBV) a Buy Now? Zacks

   X     

3 months Regeneron Pharmaceuticals, Inc. (REGN) Jefferies London Healthcare Conference (Transcript) Seeking Alpha

   X     

3 months Phathom Pharmaceuticals (PHAT) Upgraded to Buy: Here’s What You Should Know Zacks

   X     

3 months Vertex Pharmaceuticals Incorporated (VRTX) Presents at Stifel 2024 Healthcare Conference (Transcript) Seeking Alpha

   X     

3 months How Much Upside is Left in Rigel (RIGL)? Wall Street Analysts Think 28.28% Zacks

   X     

3 months After Golden Cross, Milestone Pharmaceuticals (MIST)’s Technical Outlook is Bright Zacks

   X     

3 months Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock? Zacks

   X     

3 months Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know Zacks

   X     

3 months Zacks.com featured highlights Rigel, Synchrony Financial, SkyWest, Allient and Rush Street Interactive Zacks

   X     

3 months NRx Pharmaceuticals, Inc. (NRXP) Q3 2024 Earnings Call Transcript Seeking Alpha

   X     

3 months Elite Pharmaceuticals’ Stock Up Despite Q2 Earnings Decline Zacks

   X     

3 months Jazz Pharmaceuticals: High Uncertainty, Low Risk Seeking Alpha

   X     

3 months Wall Street Analysts Believe Tarsus Pharmaceuticals (TARS) Could Rally 41.09%: Here’s is How to Trade Zacks

   X     

3 months Here’s Why Ionis Pharmaceuticals (IONS) is Poised for a Turnaround After Losing -13.46% in 4 Weeks Zacks

   X     

3 months ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis Study Zacks

   X     

3 months What Makes Eton Pharmaceuticals (ETON) a Good Fit for ‘Trend Investing’ Zacks

   X     

3 months Elite Pharmaceuticals, Inc. (ELTP) Q2 2025 Earnings Conference Call Transcript Seeking Alpha

   X     

3 months Inovio Pharmaceuticals, Inc. (INO) Q3 2024 Earnings Call Transcript Seeking Alpha

   X     

3 months Inovio Pharmaceuticals, Inc. 2024 Q3 – Results – Earnings Call Presentation Seeking Alpha

   X     

3 months 60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q3 Loss, Misses Revenue Estimates Zacks

   X     

3 months Syros Stock Plunges as Lead Cancer Study Fails to Meet Primary Goal Zacks

   X     

3 months New Strong Buy Stocks for November 14th Zacks

   X